Obstetric Emergencies

Ectopic Pregnancy

Definition

  • Any pregnancy occurring outside the uterine cavity
Location
  • 95% of all ectopic pregnancies occur in the fallopian tubes with 5% being ovarian or abdominal pregnancies.
  • Heterodoxies pregnancy, described as simultaneous intrauterine and ectopic pregnancy may also occur.

Incidence

  • Annually 70,000 cases of ectopic pregnancy occur in the United States with a current incidence of 20 ectopics per 1000 pregnancies.
  • The incidence of Heterodoxies pregnancy is 1 in 4000 pregnancies.

Clinical Presentation

  • Classic triad-Seen in < 50% of patients
  • Abdominal or pelvic pain
  • Missed menstrual period with associated abnormal vaginal bleeding
  • Pelvic examination demonstrates a tender adnexal mass
  • The pelvic pain when it is present is usually unilateral, severe and sudden, although there may be significant variability in quality, intensity, duration and location. Up to 10% of patients seen with ectopic pregnancy present with no pain.
  • Adnexal tenderness is present in 96% of cases, and there may also be associated cervical motion tenderness.
  • The uterus is perceived to be of normal size in approximately 71% of cases.

    Table Risk factors Obstetric Emergencies
  • Previous history of ectopic pregnancy
  • Pelvic inflammatory disease (PID)
  • Tubal surgery /pelvic surgery
  • Assisted reproduction
  • DES exposure
  • Intrauterine contraceptive devices (IUD)
  • Table Differential diagnosis of ectopic pregnancy
  • Appendicitis
  • Salpingitis
  • Ovarian torsion
  • Threatened abortion
  • Gastroenteritis
  • Urinary tract infection early pregnancy
  • Urolithiasis in early pregnancy
  • Dysfunctional uterine bleeding
  • Normal intrauterine pregnancy
  • Corpus luteum cyst
  • The presence of a palpable adnexal mass or fullness with associated tenderness is present in up to two-thirds of patients however its absence does not rule out the possibility of an ectopic pregnancy.
  • Vaginal bleeding is generally less than normal menses. Uterine decidual tissue casts may be passed in 5-10% of patients and can be mistaken for tissue from a spontaneous abortion.
  • The presence of hypotension and/or tachycardia is the presenting sign in < 5% of ectopic pregnancies and is usually associated with ectopic rupture. In the case of ectopic pregnancy rupture, peritoneal signs may be present on abdominal examination secondary to hemoperitoneum. In the unruptured ectopic pregnancy, the vital signs are more likely to be normal.

Rupture of an Ectopic Pregnancy

  • Rupture of an ectopic pregnancy is associated with:
  • syncope
  • sudden onset of severe pelvic/abdominal pain
  • hypotension
  • When an ectopic pregnancy ruptures, there occurs hemorrhage into the peritoneal cavity leading to peritoneal signs.
  • Hemorrhage from ectopic pregnancy is the major cause of pregnancy-related death during the first trimester.
  • Maternal death in these patients is often related to a delay in initial diagnosis.

Diagnostic Evaluation

  • B-HCG-Beta Human Chorionic Gonadotropin
  • All female patients of child-bearing years who present with abdominal and/or pelvic pain should have an immediate bedside urine HCG performed. A HCG level >25 mIU/ml is considered positive.
  • In the case of a known pregnancy a quantitative serum B-HCG should be performed to assist with evaluation and serve as a baseline marker.
  • B-HCG levels can be useful in determining the optimal timing of ultrasound visualization of a gestational sac. A gestational sac can usually be visualized by transvaginal ultrasound when the quantitative B-HCG is approximately 2000 mIU/ml.
  • Progesterone
  • Progesterone is produced by the corpus luteum during pregnancy. A progesterone level >25 ng/ml is consistent with a viable intrauterine pregnancy with a 97.5% sensitivity. Lower levels however do not reliably correlate with the location of the patient�s pregnancy with gynecologic emergencies.
  • There is not sufficient data available at this time to recommend its routine use in the evaluation of ectopic pregnancy.

    Table Ultrasound findings in ectopic pregnancy (one or more present)
  • Empty uterus
  • Decidual reaction (pseudogestational sac)
  • Free fluid in the culdosac
  • Cystic or complex adnexal mass
  • Live embryo visualized in the adnexa
  • Complete Blood Count (CBC)
  • Hemoglobin/hematocrit-Initial Hg/Hct serves as a baseline for later comparison. Initial values may be normal, however a low Hg/Hct initially or an acute drop over the first several hours is concerning when considering the possibility of ectopic pregnancy in your differential diagnosis.
  • White blood count (WBC)-Not useful in the diagnosis of ectopic pregnancy,
  • 50% of ectopic pregnancies have a normal WBC. May be helpful for identifying other potential entities in your differential diagnosis once ectopic pregnancy has been ruled out.
  • Rh /Type and Screen
  • Should the patient have an ectopic pregnancy, especially a ruptured ectopic pregnancy and be hemodynamically compromised, they may need blood to be transfused along with appropriate resuscitation fluids. If the patient is Rh negative, they will need to receive Rh immune globulin (RhoGAM) to prevent isoimmunization.
  • Ultrasound
  • The primary purpose of ultrasound in the diagnosis of ectopic pregnancy is to demonstrate the location of the pregnancy. Ultrasound helps us to determine whether or not the pregnancy is an intrauterine pregnancy (IUP) or an ectopic pregnancy.
    The ultrasound results can be improved with the use of color doppler.
  • It is suggestive of ectopic pregnancy if the uterus is empty in appropriately advanced pregnancy by date of LMP or the quantitative HCG result.
  • Discrimination level-the HCG level necessary to visualize an intrauterine pregnancy by ultrasound.
  • Transvaginal = 1800-2000 mIU/ml
  • Transabdominal = 6000-6500 mIU/ml.

Emergency Department Management

  • The stable patient with low clinical suspicion and inconclusive testing may be followed as an outpatient by OB/GYN consult with serial quantitative HCG and ultrasound evaluation.
  • The stable patient with high clinical suspicion should have immediate OB/GYN consult. The possible options are laparoscopy with appropriate surgical intervention if an ectopic pregnancy is identified. Another possible option at the discretion of the OB/ GYN consult is medical treatment with systemic methotrexate. Methotrexate inhibits DNA synthesis and cell multiplication in the developing embryo. Methotrexate can be used in the stable patient with an ectopic pregnancy <3.5 cm.
  • The unstable patient should immediately have:
  • two large bore IVs with normal saline
  • be place on a cardiac monitor and pulse oximetry
  • receive supplemental oxygen
  • have a CBC, PT/PTT, type and cross for 4 units of packed red blood cells (PRBC) and a STAT bedside ultrasound
  • an immediate OB/GYN consultation

    Table Indications for methotrexate usage in ectopic pregnancy
  • Ectopic pregnancy unruptured and < 3.5 cm in greatest diameter
  • Desire for future fertility
  • No active bleeding /hemoperitoneum
  • Quantitative HCG level doesn�t exceed 15,000 mIU/ml
  • The patient has no contraindication to methotrexate
  • the operating room staff should also be made aware as the patient most likely will be admitted directly to the OR for laparoscopy/laparotomy.
  • Should in a rare circumstance ultrasound not be available for patient evaluation then a culdocentesis may be performed. The procedure is done by aspiration of the contents from the pouch of Douglas entered by way of the posterior fornix. The aspiration of nonclotting blood is considered a positive test that is suspicious for ectopic pregnancy. If no blood is aspirated it is considered a nondiagnostic test. The false positive rate is approximately 5%.

Vaginal Bleeding in the First Half of Pregnancy

Forty percent of pregnant patients present with some degree of vaginal bleeding during early pregnancy. Approximately one-half of these will progress on to spontaneously abort. The vast majority of these spontaneous abortions occur prior to 8 wk of gestation. At least half of all spontaneous abortions are due to genetic abnormalities; the rest being due to a combination of factors such as uterine abnormalities, incompetent cervix, progesterone deficiency, tobacco or alcohol use.
Once again, one must always consider ectopic pregnancy in the differential when evaluating the pregnant patient with vaginal bleeding. The patient with unilateral pelvic pain and vaginal bleeding needs thorough evaluation to differentiate early abortion from ectopic pregnancy.

Definitions

  • Threatened Abortion-Uterine bleeding in the first 20 wk of pregnancy without any passage of tissue or cervical dilatation. The cervical os is closed.
  • Inevitable Abortion-Uterine bleeding in the first 20 wk of pregnancy without any passage of tissue but with a dilated cervical os.
  • Incomplete Abortion-Uterine bleeding in the first 20 wk of pregnancy with a dilated cervical os and only partial expulsion of the products of conception.
  • Complete Abortion-Uterine bleeding in the first 20 wk of pregnancy with complete expulsion of all the products of conception.
  • Missed Abortion-Fetal death in utero at < 20 wk gestation with the products of conception retained.
  • Septic Abortion-This is an incomplete abortion in which infection has ascended into the uterus causing endometritis, parametritis and peritonitis.
  • Blighted Ovum-An embryo that has failed to develop, although there is an identifiable gestational sac, can also lead to uterine bleeding.
  • Molar Pregnancy/Gestational Trophoblastic Disease-Occurs in 1/2000 pregnancies; tumors that arise from proliferation of the placental trophoblast and occur in both a benign and malignant form. A fetus is generally absent in this process. These patients present with vaginal bleeding in the first half of pregnancy 90% of the time. They generally have higher than expected serum HCG levels and their pelvic ultrasound shows a classic snow storm appearance caused by intrauterine hydropic villi. OB/Gyn consultation is necessary for treatment.

Clinical Evaluation

  • Obtain a detailed menstrual history from the patient.
  • Information that is important to obtain in this history includes:
  • the date of the last normal menstrual period
  • the date of the last menstrual period
  • the number of pads used per hour can help to quantify the amount of vaginal bleeding that has occurred.
  • Past OB/GYN history should be obtained to include the number of prior pregnancies ,the number of term/preterm deliveries and the number of abortions both spontaneous and therapeutic
  • An important step in the evaluation of vaginal bleeding in pregnancy is the complete pelvic examination which allows the localization and the quantification of the source of vaginal bleeding.
  • Bleeding from the cervical os this indicates a uterine source.
  • It should be noted whether or not the internal cervical os is open or closed and whether or not there are any products of conception present at the cervical os.
  • It can be determined whether or not the internal cervical os is open by gentle insertion of a finger into the os on bimanual examination. Ring forceps can also be carefully used to make this evaluation. Force should never be used in either of these techniques.
  • The uterus should be evaluated for tenderness, size, shape and consistency.
  • The patient�s adnexa should be palpated for the presence of masses and/or tenderness.
  • The presence of cervical motion tenderness should be determined.

Diagnostic Evaluation

  • Standard laboratory testing to be obtained in the setting of vaginal bleeding in the first half of pregnancy should include all of the following.
  • Complete blood count (CBC)
  • Quantitative serum HCG level (to help with interpretation of ultrasound results and to serve as a baseline)
  • Rh type
  • Urinalysis obtained by catheterization (to screen for urinary tract infection which is a common cause of abortion/threatened abortion.)
  • Emergent pelvic ultrasound should be obtained to help with a definitive diagnosis and to help guide subsequent treatment. Patients with a visualized intrauterine pregnancy with a closed cervical os can be considered to have a threatened abortion. Correlation of ultrasound results with the patient�s history and physical findings will allow the type of abortion to be identified.
  • Any products of conception (tissue) passed from the cervical os should be sent to pathology for evaluation.

Emergency Department Management

  • The hemodynamically stable patient with a documented intrauterine pregnancy can usually be discharged home with a follow-up evaluation with their OB/Gyn physician in 48 h. They should be instructed to return to the Emergency Department if vaginal bleeding increases and/or returns, if they notice any passage of tissue, or if they develop significant pelvic pain or fever. The patient should be placed on pelvic rest which means no intercourse, no douching and physical activity. If the patient is limited Rh negative, they will need to receive Rh immune globulin(RhoGAM) to prevent isoimmunization.
  • In the patient who is hemodynamically unstable and/or presenting with heavy persistent vaginal bleeding:
  • intravenous access should immediately be obtained and volume resuscitation initiated with normal saline.
  • A bedside hemacue and urine pregnancy test should be obtained while awaiting formal lab results.
  • The patient should be placed on supplemental oxygen, cardiac monitor, automated blood pressure monitor and pulse oximetry.
  • An emergent bedside ultrasound should be performed looking for an intrauterine pregnancy.
  • Immediate OB/GYN consultation should be also be obtained.
  • OB/GYN consultation should be obtained regarding patients with inevitable, incomplete, missed, septic abortions or molar pregnancies.

Vaginal Bleeding in the Second Half of Pregnancy

Vaginal bleeding after 20 wk of gestation can present a complicated clinical management situation with the lives of the mother and fetus often both in serious jeopardy.

Abruptio Placentae/Placental Abruption

  • Definition-The complete or partial placental separation from the decidua basalis (uterine implantation site) after 20 wk of gestation. When this separation develops, blood vessels are ruptured leading to hematoma formation which leads to significant hemorrhaging and fetal hypoxia. DIC may also develop in this situation.

Incidence

  • Abrubtio placentae occurs in approximately 1/100 pregnancies and is the cause of approximately 14% of all stillbirths in the United States.

Clinical Presentation

  • Variability of clinical presentation is related to the quantity and location of hemorrhaging.
  • Classical findings include painful vaginal bleeding with uterine tenderness and contractions. The patient may complain of back and/or abdominal pain, and the pain is usually relatively sudden in its onset and constant in nature.
  • On exam the uterus may be firm and hypertonic.
  • Vaginal bleeding is visible approximately 80% of the time and concealed 20% of the time.
  • Fetal heart sounds and visualized fetal cardiac activity by ultrasound may be absent.
  • In a small percentage of cases usually involving very small or marginal abruptions, the patient may not present with pain.
  • Clinical evidence of DIC may be present as the abruption may activate the coagulation cascade. Early awareness of this possibility may become apparent if the patient is noted to have excessive hemorrhaging at venopuncture or intravenous access sites, mucosal/gingival hemorrhaging, easy bruising and/or hematuria.
  • Pelvic examination should be delayed until a placenta previa has been ruled out.

Emergency Department Management

  • Intravenous access should be immediately obtained.
  • The patient should be placed on a cardiac monitor, blood pressure monitor and pulse oximeter. Supplemental oxygen should be initiated.
  • CBC, PT/PTT, DIC panel, urinalysis, Rh and type and crossmatch.
  • The patient should be transfused in an attempt to keep the hematocrit >30 in the presence of active significant hemorrhage.

    Table Causes of vaginal bleeding in the 2nd half of pregnancy
  • Abruptio placentae/placental abruption
  • Placenta previa
  • Premature labor
  • Premature rupture of membranes
  • Lesions of the cervix and lower genital tract
  • Uterine rupture
  • Vasa previa
  • Table Risk factors for placental abruption
  • Hypertension
  • Preeclampsia
  • History of prior placental abruption
  • Trauma
  • Cigarette smoking
  • Increasing maternal age
  • High multiparity
  • Illicit drug use (cocaine abuse)
  • Excessive alcohol consumption
  • A Kleihauer-Betke test should also be obtained to detect fetal cells in the maternal circulation.
  • A positive Kleihauer- Betke test may be the only diagnostic finding in the presence of a very small abruption.
  • The patient should be placed on a fetal monitoring unit as soon as it is feasible and fetal heart sounds should be checked frequently.
  • An emergent bedside ultrasound should be performed.
  • Ultrasound may not always be able to identify placental abruption however visualization of the placenta will allow one to rule out a placenta previa. When abruption is visualized on ultrasound it appears as a hypoechoic area between the placenta and the uterine wall.
  • Magnetic resonance imaging (MRI)is able to detect placental abruption with a higher degree of accuracy than ultrasound and has been shown to be safe in pregnancy.
    The limitations of MRI are its lack of uniform availability as well as the inability to monitor hemodynamically unstable patients in the scanner.
  • Obtain immediate OB/GYN consult while performing your evaluation.
  • With mild placental abruption expectant management is indicated if the mother is stable. In the presence of more severe placental abruption, expedited vaginal delivery or emergent cesarean section may be necessary.

Placenta Previa

Definition

  • Placenta previa describes a situation where any part of the placenta implants in the lower uterine segment and be associated with a high risk of significant serious maternal hemorrhaging. The implantation usually occurs below the fetal presenting part.
  • Total Placenta Previa-The patient�s internal cervical os is completely covered by the placenta.
  • Partial Placenta Previa-The patient�s internal cervical os is only partially covered by the placenta.

    Table Risk factors for placenta previa.
  • Multiparity
  • Multiple gestation pregnancies
  • Previous cesarean section
  • Prior uterine scar for any reason
  • Increasing maternal age
  • Previous abortion
  • Prior placenta previa
  • Diabetes mellitus
  • Erythroblastosis fetalis
  • Any process that increases placental size
  • Marginal Placenta Previa-The placenta is located adjacent to the patient�s internal os but is not covering it.

Incidence

  • Placenta previa occurs in approximately 1/200 pregnancies in the United States.
  • Approximately 90% of placenta previas resolve spontaneously prior to term.

Clinical Presentation

  • The patient usually presents with painless vaginal bleeding in the 2nd half of pregnancy.
  • Vaginal examination should be avoided as manipulation of the placenta during the examination may cause the tearing of blood vessels leading to potentially life threatening hemorrhage to the mother and/or the fetus.

Emergency Department Management

  • When placenta previa is clinically suspected emergent obstetrical consultation should be obtained.
  • Pelvic examination should initially be avoided.
  • Intravenous access should be established with appropriate hemodynamic monitoring and pulse oximetry.
  • Blood should be obtained for a CBC, Type/Cross and Rh.
  • Ultrasound should be performed on an emergent basis.
  • Fetal monitoring should be placed.
  • Emergent cesarean section versus close observation may be the indicated treatments to be decided by the obstetrical consultant.

Hyperemesis Gravidarum.

  • It is normal to have some degree of nausea and vomiting for most patients during the course of pregnancy and these episodes are especially frequent in first 12 wk.
  • The diagnosis of hyperemesis is defined as severe refractory nausea and vomiting with evidence of dehydration, weight loss, ketonuria and increased urine specific gravity.
  • Hyperemesis gravidarum is a diagnosis of exclusion after no other cause for the patient�s symptoms are found.
Diagnostic Evaluation

  • Laboratory testing in hyperemesis gravidarum should include a CBC, electrolyte panel, urinalysis, checking for the presence of urine or serum ketones.
  • The finding of large amounts of ketones in the patient�s urine or serum indicates that the patient may be obtaining much of her caloric requirement from lipolysis due to depleted glucose and glycogen stores.

Emergency Department Management

  • The initial Emergency Department treatment of hyperemesis gravidarum includes intravenous rehydration with crystalloid solution (normal saline or lactated ringers).
  • Subsequent intravenous rehydration continues with the use of either D5-lactated Ringers or D5-normal saline.
  • Urine ketones and the specific gravity should be monitored during the course of the patients rehydration for improvement.
  • Parenteral antiemetics are frequently used for control of further nausea and vomiting. Frequently used antiemetics are promethazine (phenergan), prochlorperazine (compazine) and trimethobenzamide (tigan).
  • Potassium may need to be added to the patient�s intravenous fluids based on laboratory findings.
  • Indications for admission in a patient with hyperemesis graviderum include:
  • uncertainty regarding the etiology of the patients severe nausea and vomiting;
  • electrolyte imbalances and/or ketosis that are not resolving with treatment;
  • persistent nausea and vomiting in spite of adequate treatment; a >10% weight loss.
  • The patient who shows significant improvement in symptomatology with Emergency Department treatment is able to tolerate PO intake; has no major electrolyte abnormalities and demonstrates resolving ketosis can be discharged home.
  • The patient should be instructed to eat small frequent meals and increase oral fluid intake.
  • The patient may be discharged home with a prescription for an antiemetic, usually in the form of a rectal suppository
  • They should be instructed to be rechecked either in the Emergency Department or with their private obstetrician in 24 h.
  • The patient�s obstetrician should also be contacted to inform them of the patient�s visit to the ED.

Pregnancy Induced Hypertension

Definition

  • Hypertension in pregnancy is defined as a blood pressure =140/90 in the second half of pregnancy in a previously normotensive patient.
  • Hypertension in pregnancy occurs in approximately 5% of pregnancies.
  • In most cases, the blood pressure usually returns to normal within 10 days after delivery.
  • When severe preeclampsia develops ( >170/105), there is an increased risk of intracranial hemorrhage in the mother and also of placental abruption.
  • Preeclampsia is defined as hypertension in pregnancy occurring after 20 week�s gestation with associated proteinuria and generalized edema.
  • The most common risk factor for preeclampsia is being primigravida.
  • There is also a hereditary component to its occurrence as daughters and sisters of individuals with preeclampsia are at increased risk.
  • Eclampsia is defined as the occurrence of seizures in a patient diagnosed with preeclampsia. This occurs during the third trimester or in the immediate postpartum period. There is a significant mortality rate for both the mother and the fetus with eclampsia.
  • Chronic hypertension in pregnancy also occurs and involved the presence of hypertension before the onset of pregnancy that continues during and persists long after the completion of the pregnancy. Despite the chronic nature of this underlying condition, preeclampsia and eclampsia can both can occur in these patients.

    Table Differential diagnosis for severe nausea and vomiting in early pregnancy
  • Hyperememesis gravidarum
  • Hepatitis
  • Viral gastroenteritis
  • Appendicitis
  • Partial intestinal obstruction
  • Diabetic ketoacidosis
  • Molar pregnancy/gestational trophoblastic disease
  • Urinary tract infection
  • Multiple gestation pregnancy
  • Migraine
  • Gallbladder disease
  • Transient hypertension is hypertension that develops in the latter half of the pregnancy. It is very mild hypertension that doesn�t compromise the pregnancy and spontaneously regresses in the postpartum period.
  • The HELLP syndrome is a clinical variant of preeclampsia. The letters stand for H-Hemolysis, EL-Elevated liver enzymes and LP-Low platelets.
  • This syndrome tends to occur more commonly in the multiparous patient.
  • Along with the usual signs and symptoms of preeclampsia, the patient with HELLP syndrome complains of epigastric or right upper quadrant abdominal pain.
  • Diagnosis of this syndrome can be made through obtaining an adequate history and physical along with supporting laboratory testing such as abnormal liver function test, decreased platelet count and hemolysis.
  • As a form of preeclampsia, the initial treatment of the HELLP syndrome is the same as for preeclampsia.

Clinical Presentation

  • The diagnosis of preeclampsia is made in the presence of the following:
  • Sustained systolic blood pressure =140 or diastolic blood pressure =90 measured on two separate occasions =6 h apart
    AND EITHER
  • Significant proteinuria
    OR
  • Generalized edema or weight gain of at least 5 lb in 1 wk
  • Although preeclampsia usually occurs after 20 wk gestation, it may be seen earlier in the presence of molar pregnancy.
  • In cases of severe preeclampsia the patient may also complain of scotomas, severe headache and upper abdominal pain.

Diagnostic Evaluation

  • Laboratory evaluation should include a CBC with a peripheral blood smear, platelet count, liver function tests, electrolytes, blood type and screen and urinalysis.
  • If the fetal gestational age is < 24 wk (nonviable), intermittent fetal heart rate assessment should be performed. If the fetal gestational age is >24 wk, then fetal monitoring and biophysical profile should be obtained.

Emergency Department Management

  • When blood pressure is noted at this level it should be lowered with either intravenous hydralazine or labetalol with a goal of a systolic pressure of 140-150 and a diatolic pressure of 90-100 mm Hg.

    Table Risk factors for the development of preeclampsia and eclampsia
  • Chronic hypertension
  • Primigravida
  • Family history of preeclampsia / eclampsia
  • Multiple gestation pregnancy
  • Extremes of age
  • Molar pregnancy
  • Diabetes mellitus
  • Chronic renal disease
  • Infrequent or nonexistent prenatal medical care
  • Magnesium sulfate is also administered to these patients to prevent seizures (eclampsia) from developing.
  • Magnesium sulfate is loaded by giving 4 g intravenously over 20 min followed by an infusion at 2 g/h.
  • Careful monitoring of the patient�s respiratory status, deep tendon reflexes and urine output are necessary to avoid magnesium toxicity.
  • When symptomatic magnesium toxicity is suspected, it can be reversed by intravenous administration of 10 ml of 10% calcium gluconate over 10 min.
  • Obstetrical consultation should also be obtained to further manage and admit the patient. Early or expedited delivery of the fetus may be indicated for both maternal and fetal well being.

Cardiopulmonary Arrest during Pregnancy

  • The incidence of cardiac arrest is approximately 1 in every 30,000 pregnancies.
  • The most common etiologies are pulmonary embolism, trauma, post-partum hemorrhage with hypovolemia, amniotic fluid embolism and congenital/acquired cardiac disease.
  • In the treatment of cardiac arrest in pregnancy initial resuscitative measures and procedures should be employed as they would in the nonpregnant patient.
  • Large bore intravenous access should be obtained at a site above the diaphragm so as to enhance the systemic circulation of resuscitation medications. Again, vena caval compression may decrease venous return and medications administered below the diaphragm may be delayed in their ability to reach the central circulation in a timely manner.
  • The standard medications indicated in the Current ACLS Guidelines are considered safe for use in the pregnant cardiopulmonary arrest patient based on limited data.
  • Electrical therapy which includes defibrillation or cardioversion are performed if clinically indicated in the same manner and with the same energy levels as in the non pregnant patient.
  • Perimortem C-section may be clinically indicated. The circumstances regarding the arrest , gestational age, potential survival of the fetus and the time interval since the onset of the maternal cardiac arrest are all factors to be considered when making this decision.
  • If the postmortem C-section can be performed in < 5 min from the onset of the maternal cardiac arrest there is a good prognosis for the survival of a viable infant.
  • The emergency physician must also be prepared to perform a neonatal resuscitation and have appropriate equipment and staff available should it be needed.
  • Bedside ultrasound in the emergency department is extremely helpful in the decision making process regarding whether to initiate a perimortem C-section by providing information regarding fetal age and viability.
  • If gestational age is >20 wk and there is positive fetal cardiac activity perimortem, C-section may be indicated.
       
eXTReMe Tracker